Pathology

Laboratory Technician C

Our faculty at the Icahn Institute and Department of Genetics and Genomic Sciences, are our most important asset in making scientific breakthroughs a reality.

George Diaz, MD, PhD, Professor of Genetics and Genomic Sciences and Pediatrics details why he became a doctor and why helping people fuels his everyday work.

Faculty Spotlight: George Diaz, MD, PhD

The Metabolic Genetics Group and Recanati Miller Transplantation Institute (RMTI) at Mount Sinai work together to treat pediatric patients with inherited disorders of metabolism. The group consists of doctors and specialists from the Division of Medical Genetics and Genomics, the Recanati Miller Transplantation Institute (RMTI), the Division of Pediatric Hepatology, and the Division of Pediatric Nephrology and Hypertension.
 
While organ transplant can be a very effective therapies for inherited disorders of metabolism, the path that patients and families follow can be very complex.  Access to integrated and coordinated care is essential as the population navigates a complex care pathway with multiple obstacles, and put patients at risk for complications. Specialists at Mount Sinai are changing the care paradigm to deliver the best possible outcomes for our patients. We formalized an integrated approach that involves decision-making support beyond the acute and/or critical phases of illness, avoids siloed care, and addresses challenges for short-term course and long-term prognosis.

Integrated Metabolic Liver Transplant Program at Mount Sinai

Newborn screening is the most expansive and longstanding application of personalized medicine in pediatrics. As the number and type of screened disorders continues to increase, it is important that providers keep abreast of the upcoming trends in newborn screening. This webinar will update practitioners on the core principles of newborn screening, the implications of positive screens for families and providers and identify resources available to assist providers in caring for patients identified as at risk for inherited genetic disorders by newborn screening.

Hosted by George Diaz, MD, PhD, Chief, Division of Medical Genetics and Genomics, Mount Sinai Health System

Video

Video